KA
LLY icon

KLCM Advisors’s Eli Lilly LLY Stock Holding History

KLCM Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
1,142
-185
-14% -$188K 0.09% 121
2025
Q4 		$1.43M Buy
1,327
+7
+0.5% +$6.69K 0.12% 93
2025
Q3 		$1.01M Sell
1,320
-5,592
-81% -$4.16M 0.1% 93
2025
Q2 		$5.39M Buy
6,912
+65
+0.9% +$50.5K 0.57% 36
2025
Q1 		$5.66M Hold
6,847
– – 0.66% 37
2024
Q4 		$5.29M Hold
6,847
– – 0.61% 34
2024
Q3 		$6.07M Sell
6,847
-375
-5% -$337K 0.72% 32
2024
Q2 		$6.54M Buy
7,222
+50
+0.7% +$40K 0.81% 32
2024
Q1 		$5.58M Sell
7,172
-651
-8% -$463K 0.72% 32
2023
Q4 		$4.56M Buy
7,823
+1,137
+17% +$664K 0.7% 35
2023
Q3 		$3.59M Buy
6,686
+148
+2% +$76.3K 0.68% 38
2023
Q2 		$3.07M Buy
6,538
+309
+5% +$130K 0.6% 39
2023
Q1 		$2.14M Buy
6,229
+90
+1% +$30.4K 0.42% 45
2022
Q4 		$2.25M Buy
6,139
+50
+0.8% +$17.7K 0.46% 41
2022
Q3 		$1.97M Buy
6,089
+45
+0.7% +$14.3K 0.46% 42
2022
Q2 		$1.96M Sell
6,044
-95
-2% -$28.5K 0.44% 42
2022
Q1 		$1.76M Buy
6,139
+200
+3% +$51.5K 0.37% 40
2021
Q4 		$1.64M Buy
5,939
+200
+3% +$50.7K 0.36% 40
2021
Q3 		$1.33M Hold
5,739
– – 0.28% 43
2021
Q2 		$1.32M Buy
5,739
+95
+2% +$19.1K 0.29% 41
2021
Q1 		$1.05M Hold
5,644
– – 0.24% 48
2020
Q4 		$953K Buy
5,644
+31
+0.6% +$4.63K 0.24% 50
2020
Q3 		$831K Hold
5,613
– – 0.24% 53
2020
Q2 		$922K Hold
5,613
– – 0.26% 49
2020
Q1 		$779K Buy
5,613
+7
+0.1% +$962 0.25% 49
2019
Q4 		$737K Sell
5,606
-333
-6% -$38.6K 0.16% 52
2019
Q3 		$664K Hold
5,939
– – 0.17% 51
2019
Q2 		$658K Sell
5,939
-33
-0.6% -$3.89K 0.16% 52
2019
Q1 		$775K Hold
5,972
– – 0.19% 50
2018
Q4 		$691K Hold
5,972
– – 0.2% 49
2018
Q3 		$641K Hold
5,972
– – 0.16% 51
2018
Q2 		$510K Hold
5,972
– – 0.13% 54
2018
Q1 		$462K Buy
5,972
+372
+7% +$29.9K 0.13% 55
2017
Q4 		$473K Hold
5,600
– – 0.12% 56
2017
Q3 		$479K Hold
5,600
– – 0.13% 56
2017
Q2 		$461K Hold
5,600
– – 0.13% 53
2017
Q1 		$471K Hold
5,600
– – 0.13% 44
2016
Q4 		$412K Hold
5,600
– – 0.12% 53
2016
Q3 		$449K Hold
5,600
– – 0.14% 46
2016
Q2 		$441K Hold
5,600
– – 0.15% 49
2016
Q1 		$403K Hold
5,600
– – 0.14% 47
2015
Q4 		$472K Sell
5,600
-313
-5% -$26K 0.17% 42
2015
Q3 		$495K Hold
5,913
– – 0.18% 40
2015
Q2 		$494K Sell
5,913
-200
-3% -$15.2K 0.12% 49
2015
Q1 		$444K Buy
6,113
+100
+2% +$7.12K 0.12% 46
2014
Q4 		$415K Buy
6,013
+413
+7% +$27.9K 0.11% 48
2014
Q3 		$363K Hold
5,600
– – 0.1% 47
2014
Q2 		$348K Sell
5,600
-32
-0.6% -$1.91K 0.08% 51
2014
Q1 		$331K Sell
5,632
-968
-15% -$54K 0.09% 53
2013
Q4 		$337K Hold
6,600
– – 0.09% 55
2013
Q3 		$332K Hold
6,600
– – 0.09% 54
2013
Q2 		$324K Buy
+6,600
New +$359K 0.1% 50

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KLCM Advisors's LLY Position: Q1 2026 in Review

KLCM Advisors reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $188K and leaving 1,142 shares worth $1.05M. The position accounts for 0.09% of the portfolio, ranked #121.

KLCM Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.54M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • KLCM Advisors held 1,142 shares of Eli Lilly worth $1.05M as of Q1 2026.
  • KLCM Advisors sold 185 Eli Lilly shares in Q1 2026, an estimated $188K.
  • Eli Lilly made up 0.09% of KLCM Advisors's portfolio in Q1 2026, its #121 holding.
  • KLCM Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • KLCM Advisors's Eli Lilly position peaked at $6.54M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on KLCM Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.